Çelik Hande, Abdullayev Ruslan, Akçaboy Erkan Y, Baydar Mustafa, Göğüş Nermin
Anesthesiology Department, Kocaeli Gölcük Necati Çelik Hospital, Kocaeli, Turkey.
Anesthesiology Department, Adiyaman University Research Hospital, Adiyaman, Turkey.
Braz J Anesthesiol. 2016 Jan-Feb;66(1):44-9. doi: 10.1016/j.bjane.2014.07.013. Epub 2015 Mar 29.
Tourniquet pain is one of the major obstacles for intravenous regional anesthesia. We aimed to compare tramadol and lornoxicam used in intravenous regional anesthesia as regards their effects on the quality of anesthesia, tourniquet pain and postoperative pain as well.
After the ethics committee approval 51 patients of ASA physical status I-II aged 18-65 years were enrolled. The patients were divided into three groups. Group P (n = 17) received 3mg/kg 0.5% prilocaine; group PT (n = 17) 3mg/kg 0.5% prilocaine + 2 mL (100mg) tramadol and group PL (n = 17) 3mg/kg 0.5% prilocaine + 2 mL (8 mg) lornoxicam for intravenous regional anesthesia. Sensory and motor block onset and recovery times were noted, as well as tourniquet pains and postoperative analgesic consumptions.
Sensory block onset times in the groups PT and PL were shorter, whereas the corresponding recovery times were longer than those in the group P. Motor block onset times in the groups PT and PL were shorter than that in the group P, whereas recovery time in the group PL was longer than those in the groups P and PT. Tourniquet pain onset time was shortest in the group P and longest in the group PL. There was no difference regarding tourniquet pain among the groups. Group PL displayed the lowest analgesic consumption postoperatively.
Adding tramadol and lornoxicam to prilocaine for intravenous regional anesthesia produces favorable effects on sensory and motor blockade. Postoperative analgesic consumption can be decreased by adding tramadol and lornoxicam to prilocaine in intravenous regional anesthesia.
止血带疼痛是静脉区域麻醉的主要障碍之一。我们旨在比较曲马多和氯诺昔康在静脉区域麻醉中对麻醉质量、止血带疼痛及术后疼痛的影响。
经伦理委员会批准,纳入51例年龄在18 - 65岁、ASA身体状况为I - II级的患者。将患者分为三组。P组(n = 17)接受3mg/kg的0.5%丙胺卡因;PT组(n = 17)接受3mg/kg的0.5%丙胺卡因 + 2 mL(100mg)曲马多;PL组(n = 17)接受3mg/kg的0.5%丙胺卡因 + 2 mL(8mg)氯诺昔康用于静脉区域麻醉。记录感觉和运动阻滞的起效及恢复时间,以及止血带疼痛和术后镇痛药物的消耗量。
PT组和PL组的感觉阻滞起效时间较短,而相应的恢复时间比P组长。PT组和PL组的运动阻滞起效时间比P组短,而PL组的恢复时间比P组和PT组长。止血带疼痛的起效时间在P组最短,在PL组最长。各组间止血带疼痛无差异。PL组术后镇痛药物的消耗量最低。
在丙胺卡因中添加曲马多和氯诺昔康用于静脉区域麻醉对感觉和运动阻滞产生有利影响。在静脉区域麻醉中,在丙胺卡因中添加曲马多和氯诺昔康可减少术后镇痛药物的消耗量。